What is Maolate used for?

Maolate is indicated for Spasticity.

Maolate is developed by Pfizer.

What development phase is Maolate in?

Maolate is FDA-approved (marketed).

What is the generic name of Maolate?

CHLORPHENESIN CARBAMATE is the generic (nonproprietary) name of Maolate.

Last reviewed 2026-04-20 · How we verify

Maolate (CHLORPHENESIN CARBAMATE)

Pfizer · FDA-approved approved Small molecule Quality 17/100

At a glance

Generic name	CHLORPHENESIN CARBAMATE
Sponsor	Pfizer
Modality	Small molecule
Therapeutic area	Neuroscience
Phase	FDA-approved
First approval	1965

Approved indications

Spasticity

Common side effects

No common side effects on file.

Key clinical trials

Hydroxychloroquine and Chlorphenesin Carbamate in Combination With mFOLFIRINOX in Pancreatic Cancer (PHASE1)
Effectiveness and Safety of Topical Hyaluronic Acid of Different Molecular Weights in Xerotic Skin Treatment (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Maolate CI brief — competitive landscape report
Maolate updates RSS · CI watch RSS
Pfizer portfolio CI